Research roundup

Debbie Rigby takes a look at the latest research relevant to pharmacists from around the world Diabetes treatments and risk of amputation, blindness, severe kidney failure, hyperglycaemia, and hypoglycaemia Using a large U.K. primary care database, researchers have analysed the risks and benefits of newer diabetes drugs, including glitazones and gliptins. The risk of hyperglycaemia